Citi reiterates buy rating on Arcus Biosciences after stock drops 20%

Go back to Citi reiterates buy rating on Arcus Biosciences after stock drops 20%

Form 424B5 Arcus Biosciences, Inc.

October 21, 2026 4:30 PM EDT
Table of Contents

The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and we are not soliciting an offer to buy these securities in... More

Form 8-K Arcus Biosciences, Inc. For: Oct 21

October 21, 2026 4:10 PM EDT

false 0001724521 0001724521 2026-10-21 2026-10-21... More

Form 8-K Arcus Biosciences, Inc. For: Oct 20

October 20, 2026 8:33 AM EDT

... More